“…Furthermore and even more importantly use of all these alkaloids may have additive effects further increasing the possibility of proarrhythmic risk and cardiac sudden death during administration of drugs effecting the cardiac repolarization or in certain pathophysiological conditions where repolarization reserve is impaired (including cardiac hypertrophy, hypertrophic cardiomyopathy, increased sympathetic tone, genetic defects, diabetes mellitus, renal failure, hypokalemia, hypothyroidism, etc.) [21,22]. In conclusion, the internal use of C. majus extracts or its alkaloids, berberine, chelidonine and especially sanguinarine in some situations where cardiac repolarization reserve is weak may increase the risk of potentially fatal ventricular arrhythmias.…”